Mardi C. Dier
2017
In 2017, Mardi C. Dier earned a total compensation of $2.5M as Executive Vice President, Chief Financial Officer at Portola Pharmaceuticals, a 28% decrease compared to previous year.
Compensation breakdown
| Bonus | $44,300 |
|---|---|
| Non-Equity Incentive Plan | $230,700 |
| Option Awards | $959,013 |
| Salary | $427,222 |
| Stock Awards | $798,125 |
| Other | $8,100 |
| Total | $2,467,460 |
Dier received $959K in option awards, accounting for 39% of the total pay in 2017.
Dier also received $44.3K in bonus, $230.7K in non-equity incentive plan, $427.2K in salary, $798.1K in stock awards and $8.1K in other compensation.
Rankings
In 2017, Mardi C. Dier's compensation ranked 4,493rd out of 14,666 executives tracked by ExecPay. In other words, Dier earned more than 69.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,493 out of 14,666 | 69th |
Division Manufacturing | 1,582 out of 5,768 | 73rd |
Major group Chemicals And Allied Products | 456 out of 2,074 | 78th |
Industry group Drugs | 350 out of 1,730 | 80th |
Industry Pharmaceutical Preparations | 277 out of 1,329 | 79th |
Source: SEC filing on April 24, 2018.
Dier's colleagues
We found four more compensation records of executives who worked with Mardi C. Dier at Portola Pharmaceuticals in 2017.
2017
William Lis
Portola Pharmaceuticals
Chief Executive Officer
2017
John Lawrence
Portola Pharmaceuticals
Chief Medical Officer
2017
Tao Fu
Portola Pharmaceuticals
Executive Vice President, Chief Commercial and Business Officer
2017
John Curnutte
Portola Pharmaceuticals